Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 12Stomach Neoplasms 4Prostatic Neoplasms 4Polycystic Ovary Syndrome 4Neoplasms 3Peripheral Nervous System Diseases 2Lung Neoplasms 2Inflammation 2Esophageal Neoplasms 2Cardiovascular Diseases 2Carcinoma, Intraductal, Noninfiltrating 2Weight Loss 1Rectal Neoplasms 1Psychological Well-Being 1Psoriasis 1Protein Deficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Osteoarthritis 1Obesity 1Neoplasm, Residual 1Multiple Sclerosis 1Multiple Myeloma 1Motor Activity 1Malnutrition 1Lipid Metabolism Disorders 1Healthy Subject 1

Interventions

Cyclophosphamide 21Cytarabine 15blinatumomab 13fludarabine 12Azacitidine 10venetoclax 9fludarabine phosphate 9Blood Specimen Collection 8Methotrexate 7Lenalidomide 7Dexamethasone 7Rituximab 6Mercaptopurine 6Daunorubicin 6Vincristine 5daratumumab 4Whole-Body Irradiation 4Melphalan 4Etoposide 4Busulfan 4obinutuzumab 3Radiotherapy 3Neoadjuvant Therapy 3Maintenance 3Liquid Biopsy 3Immunotherapy, Adoptive 3Idarubicin 3Granulocyte Colony-Stimulating Factor 3Drug Therapy 3Doxorubicin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neoplasm, Residual × Fish Oils × Clear all
NCT03093207 2020-11-17

Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive Periodontitis

Universidade Estadual Paulista Júlio de Mesquita Filho

Phase 2/3 Completed
34 enrolled 8 charts

Aggressive Periodontitis, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡